NCT06048692 is a Phase 3 clinical trial of Cefepime 1000 MG in Cesarean Section; Infection, sponsored by Beni-Suef University.

Who is sponsoring NCT06048692?

NCT06048692 is sponsored by Beni-Suef University.

What drugs are being tested in NCT06048692?

Interventions in NCT06048692: Cefepime 1000 MG, Ampicillin-sulbactam.

What condition does NCT06048692 study?

NCT06048692 studies Cesarean Section; Infection.

Is NCT06048692 still recruiting?

NCT06048692 is currently status unknown. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT06048692

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections

Status unknown Phase 3 Last updated 21 September 2023

What this trial tests

Phase 3 trial testing Cefepime 1000 MG in Cesarean Section; Infection in 213 participants. Status unknown.

Timeline

1 January 2023

Primary endpoint
15 September 2023

20 September 2023

Quick facts

Lead sponsor	Beni-Suef University
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	213
Start date	1 January 2023
Primary completion	15 September 2023
Estimated completion	20 September 2023
Sites	1 location across Egypt

Drugs / interventions tested

Cefepime 1000 MG — full drug profile →
Ampicillin-sulbactam

Conditions studied

Cesarean Section; Infection — all drugs for Cesarean Section; Infection →

Sponsor

Beni-Suef University

Who can join

Adults 18 to 40, female only, with Cesarean Section; Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim of this study is to evaluate the efficacy of employing cefepime (CFM) versus ampicillin/sulbactam (AMS) in lowering the rate of post-cesarean surgical site infections.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Beni-Suef University trials

Trials by the same sponsor.

NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06048692 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06048692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing